KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.75 $7.64 Friday, 26th Apr 2024 FATE stock ended at $3.80. This is 1.81% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $3.75 to a day high of $3.95.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Apr 28, 2023 $5.86 $6.11 $5.72 $6.07 2 080 988
Apr 27, 2023 $5.88 $6.03 $5.71 $5.84 1 933 752
Apr 26, 2023 $6.03 $6.12 $5.78 $5.82 1 597 198
Apr 25, 2023 $6.25 $6.46 $5.97 $6.03 2 033 308
Apr 24, 2023 $6.36 $6.40 $6.12 $6.34 1 410 516
Apr 21, 2023 $6.03 $6.23 $5.99 $6.22 2 066 141
Apr 20, 2023 $6.34 $6.35 $5.96 $6.00 2 095 534
Apr 19, 2023 $6.23 $6.52 $6.14 $6.36 1 414 340
Apr 18, 2023 $6.73 $6.74 $6.16 $6.23 2 601 123
Apr 17, 2023 $6.08 $6.66 $6.07 $6.59 2 763 934
Apr 14, 2023 $5.84 $6.22 $5.80 $6.01 10 498 333
Apr 13, 2023 $5.76 $6.29 $5.64 $6.20 3 671 343
Apr 12, 2023 $5.62 $5.90 $5.56 $5.61 2 236 187
Apr 11, 2023 $5.52 $5.71 $5.47 $5.64 1 570 936
Apr 10, 2023 $5.81 $5.81 $5.45 $5.48 2 361 929
Apr 06, 2023 $5.52 $5.89 $5.44 $5.85 2 118 153
Apr 05, 2023 $5.50 $5.65 $5.46 $5.50 1 137 559
Apr 04, 2023 $5.72 $5.89 $5.44 $5.53 1 799 429
Apr 03, 2023 $5.59 $5.89 $5.56 $5.81 1 763 415
Mar 31, 2023 $5.38 $5.73 $5.29 $5.70 1 814 027
Mar 30, 2023 $5.61 $5.66 $5.28 $5.30 1 721 720
Mar 29, 2023 $5.35 $5.58 $5.25 $5.55 2 049 203
Mar 28, 2023 $5.45 $5.47 $5.26 $5.27 1 693 367
Mar 27, 2023 $5.37 $5.62 $5.34 $5.48 2 123 649
Mar 24, 2023 $5.19 $5.43 $5.05 $5.39 1 708 975
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT